Scientists at the University of Oxford in the UK have launched the first-in-human clinical trial to test a vaccine to protect people against deadly Nipah virus.
The first participants in the Oxford trial received doses of the vaccine over the last week. The shot is based on the same technology as the one used in AstraZeneca (AZN.L) and Serum Institute of India's Covid-19 shots.
Nipah virus in Kerala: Union Health Minister confirmed that two people died in Kerala after contracting Nipah virus. Currently, seven people are under treatment out of which two more have tested positive. Know all about the deadly Nipah virus symptoms, source, treatment fatality rate and more in this Business Today Visual Story.